BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4635969)

  • 1. Synthesis and antidepressant activity of 5-phenyl-2-(2-propynylamino)-2-oxazolin-4-one and derivatives.
    Lee CM; Horrom BW; Michaels RJ; Rasmussen RM; Plotnikoff NP
    J Med Chem; 1972 Dec; 15(12):1252-5. PubMed ID: 4635969
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressant and anticonvulsant activity of 1-(5-phenyl-4-oxazolin-2-yl)-4-substituted piperazines.
    Lee CM; Plotnikoff NP
    J Med Chem; 1976 May; 19(5):731-3. PubMed ID: 1271419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant agents. 1. Chemistry and pharmacology of amino-substituted spiro(5H-dibenzo(a,d)cycloheptene-5,1'-cycloalkanes).
    Carnmalm B; Jacupovic E; Johansson L; de Paulis T; Rämsby S; Stjernström NE; Renyi AL; Ross SB; Ogren SO
    J Med Chem; 1974 Jan; 17(1):65-72. PubMed ID: 4543291
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-Arylquinolizidines, potential antidepressant agents.
    Rogers ME; Sam J
    J Med Chem; 1975 Nov; 18(11):1126-30. PubMed ID: 1177258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PS-2747: a new antidepressant agent.
    Plotnikoff N; Will F; Evans A; Meekma P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):330-42. PubMed ID: 4622667
    [No Abstract]   [Full Text] [Related]  

  • 7. L-Dopa administration to neonate chicks: effects on behavior and levels of brain biogenic amines.
    Hanig JP; Seifter J
    Experientia; 1971 Feb; 27(2):168-9. PubMed ID: 5549261
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute effects of 6-hydroxyDOPA and its interaction with DOPA on brain amine levels.
    Clarke DE; Smookler HH; Hadinata J; Chi C; Barry H
    Life Sci I; 1972 Feb; 11(3):97-102. PubMed ID: 4653197
    [No Abstract]   [Full Text] [Related]  

  • 9. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 10. Pemoline: enhancement of maze performance in young rats.
    Plotnikoff NP
    Behav Biol; 1973 Jul; 9(1):117-21. PubMed ID: 4731942
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of brain L-dopa concentration with -chymotrypsin.
    Seneca H; Henderson E
    J Am Geriatr Soc; 1973 Jun; 21(6):256-8. PubMed ID: 4710643
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral and neurochemical effects of psychotomimetic drugs in neonate chicks.
    Wallach MB; Friedman E; Gershon S
    Eur J Pharmacol; 1972 Feb; 17(2):259-69. PubMed ID: 5026400
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 15. Quipazine, a new type of antidepressant agent.
    Rodríguez R; Pardo EG
    Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemistry and pharmacology of a new potential antidepressant. (N-methyl-N-[4-chlorobenzyl-methyl-3-(10,11-dihydro-5H-dibenz(b,f) azepin-5-yl)]-propylamine hydrochloride). (Leo 640, lopraminehydrochloride).
    Eriksoo E; Rohte O
    Arzneimittelforschung; 1970 Oct; 20(10):1561-9. PubMed ID: 4394726
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 18. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice.
    Massotti M; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1974; 2(6):769-76. PubMed ID: 4549398
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral and biochemical effects of alpha-methyltyrosine in cats.
    Kitsikis A; Roberge AG
    Psychopharmacologia; 1973 Jul; 31(2):143-55. PubMed ID: 4722207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.